Olaparib (PARP inhibitor)
Treatment used for 1 condition
Total Trials
20
Total Participants
1K
Avg Effectiveness
70%
Avg Safety Score
50%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.